Sign in Register

Neptazane (methazolamide)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Methazolamide is a carbonic anhydrase inhibitor.

Methazolamide is used only in the adjunctive treatment of open-angle (noncongestive, chronic simple) or secondary glaucoma and for short-term preoperative therapy in angle-closure (obstructive, narrow-angle) glaucoma when delay of surgery is desired in order to lower intraocular pressure (IOP). Long-term use of oral carbonic anhydrase inhibitors is limited by systemic adverse effects. (See Uses: Glaucoma, in the Carbonic Anhydrase Inhibitors General Statement 52:40.12.)

Generic name: methazolamide
Pronunciation: (METH-a-ZOL-a-mide)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Neptazane

Intelligence content is not available yet.

Indications

The following indications are listed for Neptazane:

  • Angle-Closure Glaucoma
  • Open Angle Glaucoma
  • Secondary Glaucoma

Also known as: Chronic Glaucoma, Compensated Glaucoma, Glaucoma Simplex, Narrow Angle Glaucoma, Open-Angle Glaucoma, Simple Glaucoma.

Dosing

Dosage of methazolamide must be adjusted according to the patient's requirements and response. The usual adult dosage of methazolamide is 50-100 mg 2 or 3 times daily.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a 5-digit ZIP code. Searching does not change your profile.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data